Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Tickner

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2019
Cumambrin A prevents OVX-induced osteoporosis <i>via</i> the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathwaysLin Zhou, Qian Liu, Guoju Hong, et al.
Frontiers in Pharmacology|March 27, 2020
Fumitremorgin C Attenuates Osteoclast Formation and Function <i>via</i> Suppressing RANKL-Induced Signaling PathwaysYu Yuan, Kai Chen, Xi Chen, et al.
FEBS Letters|November 26, 2013
HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylationXinghuo Wu, Shek Man Chim, Vincent Kuek, et al.
Journal of Cellular Physiology|November 4, 2014
Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activityJun Yao, Jia Li, Lin Zhou, et al.
Journal of Cellular and Molecular Medicine|November 20, 2018
Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in miceHaiming Jin, Lingya Yao, Kai Chen, et al.
Journal of Cellular Physiology|August 6, 2018
Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorptionQiang Guo, Zhen Cao, Bo Wu, et al.
International Journal of Molecular Sciences|November 19, 2015
Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT PathwaysLin Zhou, Fangming Song, Qian Liu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2018
Expression Quantitative Trait Locus Study of Bone Mineral Density GWAS Variants in Human OsteoclastsBenjamin H Mullin, Kun Zhu, Jiake Xu, et al.
Journal of Cellular Biochemistry|April 5, 2016
Bafilomycin A1 Attenuates Osteoclast Acidification and Formation, Accompanied by Increased Levels of SQSTM1/p62 ProteinSipin Zhu, Sarah L Rea, Taksum Cheng, et al.
Journal of Cellular Biochemistry|January 19, 2018
Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signalingDezhi Song, Zhen Cao, Song Huang, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2019
Cumambrin A prevents OVX-induced osteoporosis <i>via</i> the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathwaysLin Zhou, Qian Liu, Guoju Hong, et al.
Frontiers in Pharmacology|March 27, 2020
Fumitremorgin C Attenuates Osteoclast Formation and Function <i>via</i> Suppressing RANKL-Induced Signaling PathwaysYu Yuan, Kai Chen, Xi Chen, et al.
FEBS Letters|November 26, 2013
HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylationXinghuo Wu, Shek Man Chim, Vincent Kuek, et al.
Journal of Cellular Physiology|November 4, 2014
Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activityJun Yao, Jia Li, Lin Zhou, et al.
Journal of Cellular and Molecular Medicine|November 20, 2018
Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in miceHaiming Jin, Lingya Yao, Kai Chen, et al.
Journal of Cellular Physiology|August 6, 2018
Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorptionQiang Guo, Zhen Cao, Bo Wu, et al.
International Journal of Molecular Sciences|November 19, 2015
Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT PathwaysLin Zhou, Fangming Song, Qian Liu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2018
Expression Quantitative Trait Locus Study of Bone Mineral Density GWAS Variants in Human OsteoclastsBenjamin H Mullin, Kun Zhu, Jiake Xu, et al.
Journal of Cellular Biochemistry|April 5, 2016
Bafilomycin A1 Attenuates Osteoclast Acidification and Formation, Accompanied by Increased Levels of SQSTM1/p62 ProteinSipin Zhu, Sarah L Rea, Taksum Cheng, et al.
Journal of Cellular Biochemistry|January 19, 2018
Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signalingDezhi Song, Zhen Cao, Song Huang, et al.
Pageof 7